| Date | Time | Source | Headline | Symbol | Company |
| 05/28/2004 | 9:00AM | PR Newswire (US) | Abstracts on Allos Therapeutics' RSR13 to Be Presented at American Society of Clinical Oncology Annual Meeting | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/25/2004 | 12:23PM | PR Newswire (US) | Wolf Haldenstein Adler Freeman and Herz LLP Commences Class Action Lawsuit on Behalf of Allos Therapeutics, Inc. Shareholders | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/24/2004 | 5:13PM | PR Newswire (US) | Geller Rudman Announces Class Action Lawsuit Against Allos Therapeutics, Inc. on Behalf of Investors | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/24/2004 | 4:13PM | PR Newswire (US) | Shareholder Class Action Filed Against Allos Therapeutics, Inc. by the Law Firm of Schiffrin & Barroway, LLP | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/21/2004 | 6:00PM | PR Newswire (US) | Weinstein Kitchenoff Scarlato Karon & Goldman Ltd. Announces Class Action Lawsuit Against Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/06/2004 | 7:00AM | PR Newswire (US) | Allos Therapeutics Reports First Quarter 2004 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/04/2004 | 6:25PM | PR Newswire (US) | Allos Therapeutics to Hold Q1 2004 Financial Results Conference Call and Webcast on Thursday, May 6 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 05/03/2004 | 6:04PM | PR Newswire (US) | FDA Advisory Committee Does Not Recommend Approval of RSR13 as Adjunctive Therapy for the Treatment of Brain Metastases Originat | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/30/2004 | 5:30PM | PR Newswire (US) | Allos to Discuss ODAC Panel Recommendation on Monday May 3, 2004 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/12/2004 | 2:54PM | PR Newswire (US) | Allos NDA to be Reviewed by FDA Advisory Committee | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/11/2004 | 3:17PM | PR Newswire (US) | American Stock Exchange to Trade Options on Three Securities | NASDAQ:ALTH | |
| 03/05/2004 | 6:59PM | PR Newswire (US) | Allos Therapeutics Files Shelf Registration Statement | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/12/2004 | 7:45AM | PR Newswire (US) | Reminder - Allos Therapeutics Management Conference Call | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/12/2004 | 7:00AM | PR Newswire (US) | Allos Begins Phase 3 Study of RSR13 in Women With Brain Metastases From Breast Cancer | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/12/2004 | 6:00AM | PR Newswire (US) | Allos Therapeutics Reports Fourth Quarter and Year-End 2003 Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/04/2003 | 6:00AM | PR Newswire (US) | Allos Completes New Drug Application for Novel Treatment for Patients With Breast Cancer and Brain Metastases | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/03/2003 | 5:30PM | PR Newswire (US) | Arizona Cancer Center Investigator Presents Positive Survival and Quality of Life Data From RSR13 Phase 3 Study | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/24/2003 | 7:00AM | PR Newswire (US) | Allos Therapeutics Announces RSR13 Phase 3 Results in Patients With Breast Cancer and Brain Metastases Will Be Highlighted at th | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/20/2003 | 5:24PM | PR Newswire (US) | Allos Therapeutics Completes $12 Million Private Placement | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/18/2003 | 12:30PM | PR Newswire (US) | Allos Therapeutics Announces Presentation of Phase 1 Results of PDX in Patients With Advanced Non-Small Cell Lung Cancer | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/17/2003 | 6:00AM | PR Newswire (US) | Allos Therapeutics Announces Presentation of RSR13 Phase 3 Results in Brain Metastases at the Eighth Annual Meeting of the Socie | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/15/2003 | 2:00PM | PR Newswire (US) | RSR13 Investigator Presented With National Tumor Foundation Research Award At Society for Neuro-Oncology Annual Meeting | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/06/2003 | 7:45AM | PR Newswire (US) | Reminder - Webcast Alert: Allos Therapeutics, Inc. Announces Third Quarter 2003 Financial Results Conference Call on the Web | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/06/2003 | 6:00AM | PR Newswire (US) | Allos Therapeutics Reports Third Quarter 2003 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/31/2003 | 7:45AM | PR Newswire (US) | Webcast Alert: Allos Therapeutics, Inc. Announces Third Quarter 2003 Financial Results Conference Call on the Web | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |